| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.828 | 0.002 | 0.828 | Anesthetic general | 0.581 0.005 DBMET00695 | ||
| 0.77 | 0.002 | 0.77 | Androgen antagonist | 0.629 0.003 DBMET00695 | ||
| 0.768 | 0.003 | 0.768 | Diuretic | 0.492 0.008 DBMET00695 | ||
| 0.742 | 0.001 | 0.742 | Aldosterone antagonist | 0.187 0.004 DBMET00695 | ||
| 0.702 | 0.001 | 0.702 | Progesterone antagonist | 0.564 0.002 DBMET00695 | ||
| 0.709 | 0.029 | 0.79 | Antiinflammatory | 0.79 0.017 DBMET00695 | DBMET00695 | |
| 0.667 | 0.001 | 0.667 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.211 0.003 DBMET00695 | ||
| 0.67 | 0.01 | 0.67 | Cholesterol antagonist | 0.634 0.014 DBMET00695 | ||
| 0.661 | 0.002 | 0.661 | Aromatase inhibitor | 0.659 0.002 DBMET00695 | ||
| 0.682 | 0.034 | 0.81 | Apoptosis agonist | 0.81 0.015 DBMET00695 | DBMET00695 | |
| 0.632 | 0.002 | 0.632 | Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor | 0.459 0.002 DBMET00695 | ||
| 0.641 | 0.027 | 0.641 | Transcription factor NF kappa B inhibitor | 0.602 0.031 DBMET00695 | ||
| 0.599 | 0.002 | 0.599 | Lipocortins synthesis antagonist | 0.533 0.003 DBMET00695 | ||
| 0.561 | 0.001 | 0.561 | 5-Alpha-reductase 1 inhibitor | 0.378 0.002 DBMET00695 | ||
| 0.561 | 0.009 | 0.561 | Hypoxia-inducible factor 1 alpha inhibitor | |||
| 0.552 | 0.004 | 0.552 | Growth factor agonist | 0.156 0.127 DBMET00695 | ||
| 0.552 | 0.005 | 0.552 | NOS3 expression enhancer | 0.138 0.085 DBMET00695 | ||
| 0.532 | 0.001 | 0.532 | 5-Alpha-reductase inhibitor | 0.448 0.002 DBMET00695 | ||
| 0.503 | 0.001 | 0.503 | 5-Alpha-reductase 2 inhibitor | 0.336 0.002 DBMET00695 | ||
| 0.519 | 0.028 | 0.64 | Immunosuppressant | 0.64 0.009 DBMET00695 | DBMET00695 | |
| 0.481 | 0.003 | 0.481 | Mineralocorticoid receptor antagonist | 0.128 0.005 DBMET00695 | ||
| 0.48 | 0.005 | 0.512 | Sodium/bile acid cotransporter inhibitor | 0.512 0.004 DBMET00695 | DBMET00695 | |
| 0.52 | 0.052 | 0.531 | Caspase 9 stimulant | 0.531 0.049 DBMET00695 | DBMET00695 | |
| 0.457 | 0.008 | 0.495 | Interferon gamma antagonist | 0.495 0.006 DBMET00695 | DBMET00695 | |
| 0.458 | 0.011 | 0.458 | P-glycoprotein inhibitor | 0.19 0.071 DBMET00695 | ||
| 0.415 | 0.001 | 0.415 | Progesterone agonist | 0.156 0.003 DBMET00695 | ||
| 0.413 | 0.005 | 0.413 | Neurotrophic factor enhancer | 0.225 0.055 DBMET00695 | ||
| 0.405 | 0.025 | 0.507 | Nitric oxide antagonist | 0.507 0.015 DBMET00695 | DBMET00695 | |
| 0.402 | 0.038 | 0.446 | Apoptosis antagonist | 0.446 0.028 DBMET00695 | DBMET00695 | |
| 0.349 | 0.001 | 0.349 | Glucose-6-phosphate dehydrogenase inhibitor | 0.065 0.006 DBMET00695 | ||
| 0.346 | 0.008 | 0.346 | Aldehyde dehydrogenase inhibitor | |||
| 0.325 | 0.023 | 0.35 | Hepatoprotectant | 0.35 0.019 DBMET00695 | DBMET00695 | |
| 0.385 | 0.091 | 0.385 | Analgesic | |||
| 0.343 | 0.049 | 0.343 | Interleukin 2 agonist | 0.294 0.078 DBMET00695 | ||
| 0.296 | 0.002 | 0.296 | Arachidonic acid antagonist | 0.25 0.005 DBMET00695 | ||
| 0.304 | 0.014 | 0.316 | Antipruritic | 0.316 0.012 DBMET00695 | DBMET00695 | |
| 0.295 | 0.006 | 0.295 | Estrogen antagonist | 0.225 0.01 DBMET00695 | ||
| 0.3 | 0.011 | 0.34 | Cholesterol synthesis inhibitor | 0.34 0.008 DBMET00695 | DBMET00695 | |
| 0.285 | 0.003 | 0.285 | Androgen agonist | 0.239 0.004 DBMET00695 | ||
| 0.272 | 0.009 | 0.319 | Farnesoid X receptor antagonist | 0.319 0.005 DBMET00695 | DBMET00695 | |
| 0.295 | 0.036 | 0.295 | Gastrin inhibitor | 0.199 0.15 DBMET00695 | ||
| 0.302 | 0.044 | 0.302 | 5 Hydroxytryptamine uptake stimulant | 0.229 0.105 DBMET00695 | ||
| 0.258 | 0.003 | 0.258 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.043 0.014 DBMET00695 | ||
| 0.252 | 0.002 | 0.252 | RNA-directed RNA polymerase stimulant | 0.122 0.005 DBMET00695 | ||
| 0.233 | 0.003 | 0.233 | Glycine receptor agonist | 0.134 0.009 DBMET00695 | ||
| 0.276 | 0.05 | 0.276 | Psychostimulant | 0.193 0.084 DBMET00695 | ||
| 0.227 | 0.002 | 0.227 | Anabolic | 0.201 0.004 DBMET00695 | ||
| 0.219 | 0.003 | 0.219 | Glucocorticoid antagonist | 0.121 0.004 DBMET00695 | ||
| 0.212 | 0.003 | 0.212 | Glycine receptor antagonist | 0.114 0.021 DBMET00695 | ||
| 0.219 | 0.014 | 0.219 | GABA receptor agonist | |||
| 0.211 | 0.008 | 0.293 | Pregnane X receptor agonist | 0.293 0.004 DBMET00695 | DBMET00695 | |
| 0.206 | 0.004 | 0.206 | Estradiol 17 beta-dehydrogenase inhibitor | |||
| 0.237 | 0.051 | 0.325 | Sigma receptor agonist | 0.325 0.034 DBMET00695 | DBMET00695 | |
| 0.253 | 0.068 | 0.31 | Angiogenesis stimulant | 0.31 0.046 DBMET00695 | DBMET00695 | |
| 0.272 | 0.088 | 0.285 | Immunostimulant | 0.285 0.083 DBMET00695 | DBMET00695 | |
| 0.182 | 0.009 | 0.182 | Estrogen receptor alpha antagonist | 0.087 0.038 DBMET00695 | ||
| 0.177 | 0.005 | 0.177 | 11-Beta-hydroxysteroid dehydrogenase 1 inhibitor | 0.116 0.009 DBMET00695 | ||
| 0.169 | 0.004 | 0.169 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.065 0.025 DBMET00695 | ||
| 0.193 | 0.03 | 0.207 | DNA polymerase I inhibitor | 0.207 0.026 DBMET00695 | DBMET00695 | |
| 0.241 | 0.079 | 0.241 | Tumour necrosis factor alpha release inhibitor | 0.196 0.112 DBMET00695 | ||
| 0.194 | 0.044 | 0.283 | Protein kinase stimulant | 0.283 0.019 DBMET00695 | DBMET00695 | |
| 0.194 | 0.044 | 0.194 | Interleukin 6 antagonist | 0.146 0.095 DBMET00695 | ||
| 0.16 | 0.011 | 0.16 | Acetylcholine release stimulant | |||
| 0.192 | 0.045 | 0.192 | Melanin inhibitor | 0.183 0.049 DBMET00695 | ||
| 0.165 | 0.02 | 0.165 | AMP-activated protein kinase stimulant | |||
| 0.15 | 0.006 | 0.15 | Na+ K+ transporting ATPase inhibitor | 0.136 0.009 DBMET00695 | ||
| 0.232 | 0.092 | 0.337 | DNA damaging | 0.337 0.045 DBMET00695 | DBMET00695 | |
| 0.187 | 0.047 | 0.187 | Lipid peroxidase inhibitor | |||
| 0.149 | 0.009 | 0.149 | GABA receptor antagonist | |||
| 0.154 | 0.015 | 0.154 | Estrogen receptor beta antagonist | 0.15 0.015 DBMET00695 | ||
| 0.15 | 0.011 | 0.23 | Estrogen agonist | 0.23 0.007 DBMET00695 | DBMET00695 | |
| 0.146 | 0.008 | 0.212 | Bile acid receptor antagonist | 0.212 0.004 DBMET00695 | DBMET00695 | |
| 0.15 | 0.016 | 0.15 | GABA A receptor agonist | |||
| 0.136 | 0.002 | 0.136 | Lipocortins synthesis agonist | 0.103 0.005 DBMET00695 | ||
| 0.137 | 0.01 | 0.137 | GABA A receptor antagonist | |||
| 0.131 | 0.005 | 0.183 | Potassium channel Kv1.3 blocker | 0.183 0.004 DBMET00695 | DBMET00695 | |
| 0.135 | 0.015 | 0.226 | CDC25A inhibitor | 0.226 0.005 DBMET00695 | DBMET00695 | |
| 0.138 | 0.024 | 0.138 | Acetylcholine nicotinic antagonist | 0.092 0.045 DBMET00695 | ||
| 0.135 | 0.022 | 0.256 | ABCA1 expression enhancer | 0.256 0.006 DBMET00695 | DBMET00695 | |
| 0.119 | 0.009 | 0.208 | Estrogen receptor beta agonist | 0.208 0.004 DBMET00695 | DBMET00695 | |
| 0.106 | 0.004 | 0.106 | GABA uptake inhibitor | 0.05 0.015 DBMET00695 | ||
| 0.102 | 0.003 | 0.102 | Glucocorticoid agonist | 0.029 0.006 DBMET00695 | ||
| 0.1 | 0.002 | 0.1 | Corticosteroid-like | 0.037 0.004 DBMET00695 | ||
| 0.102 | 0.004 | 0.102 | Estrone sulfatase inhibitor | 0.028 0.011 DBMET00695 | ||
| 0.208 | 0.113 | 0.358 | Interleukin agonist | 0.358 0.027 DBMET00695 | DBMET00695 | |
| 0.113 | 0.027 | 0.133 | Opioid kappa receptor antagonist | 0.133 0.02 DBMET00695 | DBMET00695 | |
| 0.094 | 0.009 | 0.233 | Estrogen receptor alpha agonist | 0.233 0.004 DBMET00695 | DBMET00695 | |
| 0.093 | 0.009 | 0.093 | Heme oxygenase stimulant | 0.083 0.013 DBMET00695 | ||
| 0.164 | 0.082 | 0.173 | Phospholipase C inhibitor | 0.173 0.069 DBMET00695 | DBMET00695 | |
| 0.132 | 0.05 | 0.201 | Microtubule formation inhibitor | 0.201 0.019 DBMET00695 | DBMET00695 | |
| 0.087 | 0.005 | 0.087 | Pregnane X receptor antagonist | |||
| 0.116 | 0.043 | 0.191 | Hedgehog signaling inhibitor | 0.191 0.013 DBMET00695 | DBMET00695 | |
| 0.218 | 0.145 | 0.308 | Caspase 3 stimulant | 0.308 0.075 DBMET00695 | DBMET00695 | |
| 0.131 | 0.059 | 0.131 | Adenylate cyclase inhibitor | |||
| 0.111 | 0.042 | 0.123 | Antineoplastic antibiotic | 0.123 0.038 DBMET00695 | DBMET00695 | |
| 0.126 | 0.062 | 0.126 | Anesthetic local | |||
| 0.185 | 0.123 | 0.214 | RNA-directed DNA polymerase inhibitor | 0.214 0.081 DBMET00695 | DBMET00695 | |
| 0.187 | 0.126 | 0.199 | Antioxidant | 0.199 0.114 DBMET00695 | DBMET00695 | |
| 0.061 | 0.001 | 0.061 | Transcortin receptor antagonist | |||
| 0.118 | 0.061 | 0.289 | TRPA1 agonist | 0.289 0.005 DBMET00695 | DBMET00695 | |
| 0.059 | 0.002 | 0.059 | Progesterone receptor A antagonist | 0.027 0.003 DBMET00695 | ||
| 0.12 | 0.068 | 0.152 | Alkylator | 0.152 0.045 DBMET00695 | DBMET00695 | |
| 0.063 | 0.017 | 0.071 | Opioid kappa receptor agonist | 0.071 0.014 DBMET00695 | DBMET00695 | |
| 0.136 | 0.092 | 0.136 | Ca2+-transporting ATPase inhibitor | |||
| 0.044 | 0.001 | 0.044 | 3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor | 0.024 0.002 DBMET00695 | ||
| 0.182 | 0.139 | 0.182 | 5 Hydroxytryptamine release stimulant | |||
| 0.089 | 0.049 | 0.152 | Inducible nitric-oxide synthase inhibitor | 0.152 0.016 DBMET00695 | DBMET00695 | |
| 0.055 | 0.015 | 0.146 | Parathyroid hormone antagonist | 0.146 0.002 DBMET00695 | DBMET00695 | |
| 0.055 | 0.016 | 0.145 | Liver X receptor alpha agonist | 0.145 0.004 DBMET00695 | DBMET00695 | |
| 0.108 | 0.07 | 0.108 | Monophenol monooxygenase inhibitor | |||
| 0.082 | 0.045 | 0.111 | Keratolytic | 0.111 0.025 DBMET00695 | DBMET00695 | |
| 0.091 | 0.054 | 0.091 | Ornithine decarboxylase inhibitor | |||
| 0.162 | 0.129 | 0.162 | Aldehyde oxidase inhibitor | |||
| 0.198 | 0.167 | 0.388 | Immunomodulator | 0.388 0.047 DBMET00695 | DBMET00695 | |
| 0.037 | 0.005 | 0.051 | Hedgehog signaling activator | 0.051 0.003 DBMET00695 | DBMET00695 | |
| 0.187 | 0.156 | 0.198 | Transcription factor STAT inhibitor | 0.198 0.141 DBMET00695 | DBMET00695 | |
| 0.089 | 0.058 | 0.108 | Opioid antagonist | 0.108 0.042 DBMET00695 | DBMET00695 | |
| 0.086 | 0.058 | 0.105 | Transcription factor NF kappa B stimulant | 0.105 0.034 DBMET00695 | DBMET00695 | |
| 0.129 | 0.105 | 0.129 | Adenylate cyclase stimulant | |||
| 0.031 | 0.007 | 0.224 | Vitamin D receptor antagonist | 0.224 0.002 DBMET00695 | DBMET00695 | |
| 0.048 | 0.024 | 0.09 | Liver X receptor agonist | 0.09 0.009 DBMET00695 | DBMET00695 | |
| 0.043 | 0.02 | 0.087 | Farnesoid X receptor agonist | 0.087 0.005 DBMET00695 | DBMET00695 | |
| 0.031 | 0.011 | 0.031 | Estradiol 17 beta-dehydrogenase 1 inhibitor | |||
| 0.081 | 0.063 | 0.081 | Estrogen-related receptor beta agonist | 0.078 0.073 DBMET00695 | ||
| 0.151 | 0.135 | 0.395 | Hypolipemic | 0.395 0.026 DBMET00695 | DBMET00695 | |
| 0.057 | 0.045 | 0.057 | Gonadotropin-releasing hormone receptor agonist | |||
| 0.046 | 0.033 | 0.053 | Microtubule stabilization | 0.053 0.024 DBMET00695 | DBMET00695 | |
| 0.021 | 0.011 | 0.1 | Progesterone receptor B antagonist | 0.1 0.002 DBMET00695 | DBMET00695 | |
| 0.092 | 0.085 | 0.092 | Toll-Like receptor 4 antagonist | |||
| 0.082 | 0.077 | 0.1 | Prolactin inhibitor | 0.1 0.055 DBMET00695 | DBMET00695 | |
| 0.022 | 0.017 | 0.105 | CYP24 inhibitor | 0.105 0.003 DBMET00695 | DBMET00695 | |
| 0.016 | 0.014 | 0.016 | Telomerase stimulant | |||
| 0.016 | 0.014 | 0.037 | Vitamin D receptor agonist | 0.037 0.003 DBMET00695 | DBMET00695 | |
| 0.057 | 0.057 | 0.073 | Opioid mu receptor antagonist | 0.073 0.044 DBMET00695 | DBMET00695 | |
| 0.056 | 0.058 | 0.082 | CDC25B inhibitor | 0.082 0.026 DBMET00695 | DBMET00695 | |
| 0.155 | 0.159 | 0.181 | Spasmolytic | 0.181 0.136 DBMET00695 | DBMET00695 | |
| 0.012 | 0.016 | 0.014 | NMDA receptor phencyclidine site antagonist | 0.014 0.012 DBMET00695 | DBMET00695 | |
| 0.002 | 0.007 | 0.014 | Vitamin D-like | 0.014 0.001 DBMET00695 | DBMET00695 | |
| 0.026 | 0.037 | 0.037 | Liver X receptor beta agonist | 0.037 0.018 DBMET00695 | DBMET00695 | |
| 0.026 | 0.046 | 0.052 | HMG CoA reductase inhibitor | 0.052 0.007 DBMET00695 | DBMET00695 | |
| 0.02 | 0.047 | 0.038 | Liver X receptor alpha antagonist | 0.038 0.01 DBMET00695 | DBMET00695 | |
| 0.015 | 0.044 | 0.03 | Retinoid X beta receptor antagonist | 0.03 0.004 DBMET00695 | DBMET00695 | |
| 0.032 | 0.064 | 0.047 | Opioid agonist | 0.047 0.044 DBMET00695 | DBMET00695 | |
| 0.193 | 0.225 | 0.368 | Calcium channel activator | 0.368 0.039 DBMET00695 | DBMET00695 | |
| 0.021 | 0.056 | 0.035 | ATP citrate lysase inhibitor | 0.035 0.018 DBMET00695 | DBMET00695 | |
| 0.024 | 0.06 | 0.039 | Retinoid X alpha receptor antagonist | 0.039 0.016 DBMET00695 | DBMET00695 | |
| 0.026 | 0.066 | 0.044 | Retinoid X receptor antagonist | 0.044 0.018 DBMET00695 | DBMET00695 | |
| 0.07 | 0.115 | 0.103 | Lanosterol 14 alpha demethylase inhibitor | 0.103 0.051 DBMET00695 | DBMET00695 | |
| 0.213 | 0.258 | 0.238 | Cyclophilin D inhibitor | 0.238 0.227 DBMET00695 | DBMET00695 | |
| 0.015 | 0.064 | 0.04 | Liver X receptor antagonist | 0.04 0.014 DBMET00695 | DBMET00695 | |
| 0.014 | 0.071 | 0.082 | Retinoid X receptor agonist | 0.082 0.007 DBMET00695 | DBMET00695 | |
| 0.057 | 0.116 | 0.113 | Antineoplastic alkaloid | 0.113 0.04 DBMET00695 | DBMET00695 | |
| 0.01 | 0.07 | 0.025 | Retinoid X gamma receptor agonist | 0.025 0.014 DBMET00695 | DBMET00695 | |
| 0.012 | 0.074 | 0.036 | Liver X receptor beta antagonist | 0.036 0.015 DBMET00695 | DBMET00695 | |
| 0.017 | 0.079 | 0.055 | Retinoid X alpha receptor agonist | 0.055 0.013 DBMET00695 | DBMET00695 | |
| 0.016 | 0.082 | 0.032 | Retinoid X gamma receptor antagonist | 0.032 0.01 DBMET00695 | DBMET00695 | |
| 0.021 | 0.09 | 0.038 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | 0.038 0.023 DBMET00695 | DBMET00695 | |
| 0.061 | 0.133 | 0.139 | Protein-tyrosine phosphatase 1B inhibitor | 0.139 0.05 DBMET00695 | DBMET00695 | |
| 0.068 | 0.147 | 0.172 | Amylase inhibitor | 0.172 0.054 DBMET00695 | DBMET00695 | |
| 0.173 | 0.264 | 0.351 | Antibacterial | 0.351 0.101 DBMET00695 | DBMET00695 | |
| 0.106 | 0.199 | 0.294 | Non-steroidal antiinflammatory agent | 0.294 0.029 DBMET00695 | DBMET00695 | |
| 0.087 | 0.204 | 0.143 | Vanilloid 1 agonist | 0.143 0.046 DBMET00695 | DBMET00695 | |
| 0.071 | 0.209 | 0.145 | Protein-tyrosine phosphatase inhibitor | 0.145 0.084 DBMET00695 | DBMET00695 | |
| 0.084 | 0.223 | 0.148 | Insulin secretagoues | 0.148 0.076 DBMET00695 | DBMET00695 | |
| 0.082 | 0.227 | 0.261 | Platelet adhesion inhibitor | 0.261 0.046 DBMET00695 | DBMET00695 | |
| 0.06 | 0.214 | 0.09 | T cell inhibitor | 0.09 0.037 DBMET00695 | DBMET00695 | |
| 0.042 | 0.199 | 0.1 | Expectorant | 0.1 0.068 DBMET00695 | DBMET00695 | |
| 0.025 | 0.185 | 0.04 | Alpha 1L adrenoreceptor agonist | 0.04 0.037 DBMET00695 | DBMET00695 | |
| 0.051 | 0.226 | 0.135 | Bone formation stimulant | 0.135 0.072 DBMET00695 | DBMET00695 | |
| 0.03 | 0.483 | 0.097 | Vanilloid agonist | 0.097 0.037 DBMET00695 | DBMET00695 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |